During the course of the study, subjects experienced “a significant improvement in both pain scores andhealth-related quality of life.”
Compared to occasional users and non-users, daily consumers displayed insignificant changes in SDLP following cannabis inhalation and drove at slightly slower speeds.
These results “suggest a role of the oral cannabinoid preparations in patients” with chronic migraines.
Investigators concluded, “These findings suggest that long-term near-daily cannabis use does not necessarily affect white matter microstructure.”
CBD administration at 300mgs is associated with temporary improvements in subjects’ average sleep satisfaction.